Measured Resting Energy Expenditure by Indirect Calorimetry and Energy Intake in Long-Term Growth Hormone-Treated Children with PWS
Hormone Research in Paediatrics · 2024
DOI: 10.1159/000536466 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Demi J Trueba-Timmermans und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dutch Reference Center for Prader-Willi Syndrome, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Energy Intake, Human Growth Hormone, Energy Metabolism, Prader-Willi Syndrome. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Severe obesity can develop in children with PWS when food intake is not controlled. Maintenance of body weight requires an energy balance, of which energy intake and energy expenditure are important components. Previous studies described a decreased resting energy expenditure (REE) in growth hormone (GH)-untreated children with PWS. In short-term studies, no difference in REE was found between GH-treated and untreated children with PWS. However, there are limited data on REE in children with PWS who were GH-treated for a long period.
Methods
This study describes measured REE (mREE), energy intake, and body composition during long-term GH treatment in children with PWS. Patients were treated with 1.0 mg GH/m2/day (∼0.035 mg/kg/day). REE was determined by indirect calorimetry; dietary energy intake was calculated using a 3-day dietary record. Body composition by dual-energy X-ray absorptiometry (DXA) scans.
Results
We included 52 GH-treated children with PWS with a mean (SD) age of 8.53 (4.35) years and a median (IQR) GH-treatment duration of 7 (4–11) years. mREE increased with age, but was not associated with GH-treatment duration. A higher LBM was associated with higher mREE. Mean energy intake was significantly lower compared to daily energy requirements (DER) for age- and sex-matched healthy children (p < 0.001), ranging from 23 to 36% less intake in children aged 3.5–12 years to 49% less intake in children aged 12–18 years. Fifty percent of children had a normal REE, 17.3% a decreased REE, and 32.7% an elevated REE, according to predicted REE based on measured REE in a large group of healthy children.
Conclusion
In children with PWS, mREE increases with age. GH-treatment duration is not associated, whereas LBM is an important determinant of mREE. Children with PWS have a low to very low energy intake compared to DER for age- and sex-matched children, with a declining intake when becoming older.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dutch Reference Center for Prader-Willi Syndrome, Rotterdam, The Netherlands.
- Dutch Growth Research Foundation, Rotterdam, The Netherlands.
- Department of Pediatrics, Subdivision of Endocrinology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
- Department of Pediatrics, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
Zitieren
APA
Trueba-Timmermans, D. J., Grootjen, L. N., Juriaans, A. F., Kerkhof, G. F., Rings, E. H. H. M., & Hokken-Koelega, A. C. S. (2024). Measured Resting Energy Expenditure by Indirect Calorimetry and Energy Intake in Long-Term Growth Hormone-Treated Children with PWS. Hormone Research in Paediatrics. https://doi.org/10.1159/000536466
Vancouver
Trueba-Timmermans DJ, Grootjen LN, Juriaans AF, Kerkhof GF, Rings EHHM, Hokken-Koelega ACS. Measured Resting Energy Expenditure by Indirect Calorimetry and Energy Intake in Long-Term Growth Hormone-Treated Children with PWS. Hormone Research in Paediatrics. 2024. doi:10.1159/000536466
BibTeX
@article{TruebaTimmermans2024,
author = {Trueba-Timmermans, Demi J and Grootjen, Lionne N and Juriaans, Alicia F and Kerkhof, Gerthe F and Rings, Edmond H H M and Hokken-Koelega, Anita C S},
title = {Measured Resting Energy Expenditure by Indirect Calorimetry and Energy Intake in Long-Term Growth Hormone-Treated Children with PWS},
journal = {Hormone Research in Paediatrics},
year = {2024},
doi = {10.1159/000536466}
}
EUVIMED